Extension of share buyback programme

Craneware plc

16 April 2024

 

Craneware plc

("Craneware" or the "Company" or the "Group")

Extension of share buyback programme

16 April 2024 - Craneware plc (AIM: CRW.L), the market leader in Value Cycle solutions for the US healthcare market, is pleased to announce its decision to extend the share buyback programme, which was due to expire on 17 April 2024, for a further three months to 17 July 2024, under the same terms as previously announced.

For further information, please contact:

Craneware plc	[phone]
Keith Neilson, CEO
Craig Preston, CFO
Alma Strategic Communications	[phone]
Caroline Forde, Kinvara Verdon	[e-mail]
Peel Hunt (NOMAD and Joint Broker)	[phone]
Neil Patel, Paul Gillam, Kate Bannatyne
Investec Bank PLC (Joint Broker)	[phone]
Patrick Robb, Cameron MacRitchie
Berenberg (Joint Broker)	[phone]
Mark Whitmore, Richard Andrews, Dan Gee-Summons

About Craneware

The Craneware Group (AIM:CRW.L), the market leader in automated value cycle solutions, including 340B management, collaborates with U.S. healthcare providers to plan, execute, and monitor operational and financial performance so they can continue to deliver quality care to their communities. Customers choose The Craneware Group's Trisus data and applications platform as their key to navigating the journey to financially sustainable value-based care. Trisus combines revenue integrity, cost management, 340B performance, and decision enablement into a single, SaaS-based platform. The Craneware Group - transforming the business of healthcare.

Learn more at www.thecranewaregroup.com

 

END